Difference between revisions of "Vascular sarcoma"

From HemOnc.org - A Hematology Oncology Wiki
Jump to navigation Jump to search
m (Text replacement - "http://www.esmo.org/" to "https://www.esmo.org/")
m (Text replacement - "<big>" to "")
Line 10: Line 10:
 
|}
 
|}
 
'''Note: this page does not contain any regimens. The following links will take you to disease-specific pages with regimens:'''  
 
'''Note: this page does not contain any regimens. The following links will take you to disease-specific pages with regimens:'''  
*<big>Regimens for [[Angiosarcoma|'''Angiosarcoma''' are here]]</big>.
+
*Regimens for [[Angiosarcoma|'''Angiosarcoma''' are here]]</big>.
*<big>Regimens for [[Kaposi sarcoma|'''Kaposi sarcoma''' are here]]</big>.
+
*Regimens for [[Kaposi sarcoma|'''Kaposi sarcoma''' are here]]</big>.
 
{{TOC limit|limit=3}}
 
{{TOC limit|limit=3}}
 
=Guidelines=
 
=Guidelines=

Revision as of 12:15, 3 July 2024

Section editor
Elizabethdavis2.jpg
Elizabeth J. Davis, MD
Vanderbilt University
Nashville, TN, USA
0 regimens on this page
0 variants on this page

Note: this page does not contain any regimens. The following links will take you to disease-specific pages with regimens:


Guidelines

Given the rapid change in evidence in many areas of hematology/oncology, readers are encouraged to consider any guideline published 5+ years ago to be for historical purposes, only.

ESMO

NCCN

Hemangioendothelioma, all lines of therapy

Hemangiopericytoma (solitary fibrous tumor), all lines of therapy